TY  - GEN
AU  - Peh,Jessie
AU  - Fan,Timothy M
AU  - Wycislo,Kathryn L
AU  - Roth,Howard S
AU  - Hergenrother,Paul J
TI  - The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas
SN  - 1538-8514
PY  - 2017///0629
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Caspase 3
KW  - metabolism
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Disease Models, Animal
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Humans
KW  - Hydrazones
KW  - Indoles
KW  - Melanoma
KW  - drug therapy
KW  - Mice
KW  - Mutation
KW  - Phosphorylation
KW  - Piperazines
KW  - Proto-Oncogene Proteins B-raf
KW  - genetics
KW  - Sulfonamides
KW  - Tumor Burden
KW  - Vemurafenib
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1158/1535-7163.MCT-16-0025
ER  -